Development of LNA Gapmer Oligonucleotide-Based Therapy for ALS/FTD Caused by the C9orf72 Repeat Expansion
Crossref DOI link: https://doi.org/10.1007/978-1-0716-0771-8_14
Published Online: 2020-09-01
Published Print: 2020
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sathyaprakash, Chaitra
Manzano, Raquel
Varela, Miguel A.
Hashimoto, Yasumasa
Wood, Matthew J. A.
Talbot, Kevin
Aoki, Yoshitsugu
Text and Data Mining valid from 2020-01-01
Version of Record valid from 2020-01-01
Chapter History
First Online: 1 September 2020